Invesco Ltd. Seelos Therapeutics, Inc. Transaction History

Invesco Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.51 - $0.93 $16,779 - $30,597	-32,901 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.84 - $1.71 $686 - $1,397	-817 Reduced 2.42%	32,901 $28,000
Q4 2021 Feb 14, 2022	BUY	$1.59 - $2.38 $7,992 - $11,964	5,027 Added 17.52%	33,718 $55,000
Q3 2021 Nov 15, 2021	BUY	$1.69 - $2.89 $14,174 - $24,238	8,387 Added 41.31%	28,691 $69,000
Q2 2021 Aug 17, 2021	SELL	$2.64 - $6.32 $9.09 Million - $21.8 Million	-3,443,955 Reduced 99.41%	20,304 $54,000
Q1 2021 May 17, 2021	BUY	$1.35 - $4.99 $4.68 Million - $17.3 Million	3,464,259 New	3,464,259 $17.3 Million

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $109M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.